{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:50:00Z","timestamp":1790790600346,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16-01673"],"award-info":[{"award-number":["PI16-01673"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s10072-024-07349-3","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T06:02:36Z","timestamp":1706767356000},"page":"3183-3189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Myasthenia gravis concurrent with Parkinson\u2019s disease in a Spanish cohort. Causation or correlation?"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3127-7486","authenticated-orcid":false,"given":"Josep","family":"Gamez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lorenzo-Bosquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Cuberas-Borr\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"de Fabregues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gamez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"issue":"5","key":"7349_CR1","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1212\/wnl.37.5.832","volume":"37","author":"S Ueno","year":"1987","unstructured":"Ueno S, Takahashi M, Kajiyama K, Okahisa N, Hazama T, Yorifuji S, Tarui S (1987) Parkinson\u2019s disease and myasthenia gravis: adverse effect of trihexyphenidyl on neuromuscular transmission. Neurology 37(5):832\u2013833. https:\/\/doi.org\/10.1212\/wnl.37.5.832","journal-title":"Neurology"},{"issue":"1","key":"7349_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s12967-021-03185-7","volume":"19","author":"N Salari","year":"2021","unstructured":"Salari N, Fatahi B, Bartina Y, Kazeminia M, Fatahian R, Mohammadi P, Shohaimi S, Mohammadi M (2021) Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis. J Transl Med 19(1):516. https:\/\/doi.org\/10.1186\/s12967-021-03185-7","journal-title":"J Transl Med"},{"issue":"6","key":"7349_CR3","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1212\/01.wnl.0000176067.32186.a3","volume":"65","author":"FE Somnier","year":"2005","unstructured":"Somnier FE (2005) Increasing incidence of late-onset anti\u2013AChR antibody\u2013seropositive myasthenia gravis. Neurology 65(6):928\u2013930. https:\/\/doi.org\/10.1212\/01.wnl.0000176067.32186.a3","journal-title":"Neurology"},{"issue":"5","key":"7349_CR4","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/mus.23964","volume":"48","author":"NM Alkhawajah","year":"2013","unstructured":"Alkhawajah NM, Oger J (2013) Late-onset myasthenia gravis: a review when incidence in older adults keeps increasing. Muscle Nerve 48(5):705\u2013710. https:\/\/doi.org\/10.1002\/mus.23964","journal-title":"Muscle Nerve"},{"issue":"1","key":"7349_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1055\/s-0043-1764140","volume":"43","author":"SA O'Shea","year":"2023","unstructured":"O\u2019Shea SA, Shih LC (2023) Global epidemiology of movement disorders: rare or underdiagnosed? Semin Neurol 43(1):4\u201316. https:\/\/doi.org\/10.1055\/s-0043-1764140","journal-title":"Semin Neurol"},{"issue":"3","key":"7349_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1600-0404.1988.tb03653.x","volume":"78","author":"Y Iwasaki","year":"1988","unstructured":"Iwasaki Y, Wakata N, Kinoshita M (1988) Parkinsonism induced by pyridostigmine. Acta Neurol Scand 78(3):236. https:\/\/doi.org\/10.1111\/j.1600-0404.1988.tb03653.x","journal-title":"Acta Neurol Scand"},{"issue":"3\u20134","key":"7349_CR7","first-page":"103","volume":"119","author":"Z Tasi\u0107","year":"1991","unstructured":"Tasi\u0107 Z, Stefanovi\u0107 P, Apostoloski S (1991) An unusual association of myasthenia gravis and Parkinsonism in a female patient with tuberculous lymphadenitis. Srp Arh Celok Lek 119(3\u20134):103\u2013106","journal-title":"Srp Arh Celok Lek"},{"issue":"2","key":"7349_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0303-8467(93)90008-5","volume":"95","author":"KP Kao","year":"1993","unstructured":"Kao KP, Kwan SY, Lin KP, Chang YC (1993) Coexistence of Parkinson\u2019s disease and myasthenia gravis: a case report. Clin Neurol Neurosurg 95(2):137\u2013139. https:\/\/doi.org\/10.1016\/0303-8467(93)90008-5","journal-title":"Clin Neurol Neurosurg"},{"issue":"6","key":"7349_CR9","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s00415-003-1088-y","volume":"250","author":"N Levin","year":"2003","unstructured":"Levin N, Karussis D, Abramsky O (2003) Parkinson\u2019s disease associated with myasthenia gravis. A report of 4 cases. J Neurol 250(6):766\u2013767. https:\/\/doi.org\/10.1007\/s00415-003-1088-y","journal-title":"J Neurol"},{"issue":"2","key":"7349_CR10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.parkreldis.2007.02.009","volume":"14","author":"A Fasano","year":"2008","unstructured":"Fasano A, Evoli A, Piano C, Tonali PA, Bentivoglio AR (2008) Myasthenia gravis: an unrecognized cause of head drop in Parkinson\u2019s disease. Parkinsonism Relat Disord 14(2):164\u2013165. https:\/\/doi.org\/10.1016\/j.parkreldis.2007.02.009","journal-title":"Parkinsonism Relat Disord"},{"issue":"13","key":"7349_CR11","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/mds.22704","volume":"24","author":"I Unal-Cevik","year":"2009","unstructured":"Unal-Cevik I, Temucin CM (2009) Head drop in an elder Parkinson\u2019s disease after development of myasthenia gravis. Mov Disord 24(13):2025\u20132026. https:\/\/doi.org\/10.1002\/mds.22704","journal-title":"Mov Disord"},{"key":"7349_CR12","doi-asserted-by":"publisher","first-page":"859802","DOI":"10.1155\/2011\/859802","volume":"2011","author":"S Lanfranconi","year":"2011","unstructured":"Lanfranconi S, Corti S, Baron P, Conti G, Borellini L, Bresolin N, Bersano A (2011) Anti-MuSK-positive myasthenia gravis in a patient with parkinsonism and cognitive impairment. Neurol Res Int 2011:859802. https:\/\/doi.org\/10.1155\/2011\/859802","journal-title":"Neurol Res Int"},{"issue":"3","key":"7349_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/NRL.0b013e3182173356","volume":"17","author":"IF Uludag","year":"2011","unstructured":"Uludag IF, Korucuk M, Sener U, Zorlu Y (2011) Myasthenia gravis as a cause of head drop in Parkinson disease. Neurologist 17(3):144\u2013146. https:\/\/doi.org\/10.1097\/NRL.0b013e3182173356","journal-title":"Neurologist"},{"issue":"3","key":"7349_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/1941874414522498","volume":"4","author":"LA Neuman","year":"2014","unstructured":"Neuman LA, Cheema FZ (2014) Two cases of Parkinson disease and concurrent myasthenia gravis, generalized and ocular. Neurohospitalist 4(3):117\u2013118. https:\/\/doi.org\/10.1177\/1941874414522498","journal-title":"Neurohospitalist"},{"issue":"5","key":"7349_CR15","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s10072-014-1660-5","volume":"35","author":"P Zis","year":"2014","unstructured":"Zis P, Argiriadou V, Temperikidis PP, Zikou L, Tzartos SJ, Tavernarakis A (2014) Parkinson\u2019s disease associated with myasthenia gravis and rheumatoid arthritis. Neurol Sci 35(5):797\u2013799. https:\/\/doi.org\/10.1007\/s10072-014-1660-5","journal-title":"Neurol Sci"},{"issue":"10","key":"7349_CR16","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1111\/jgs.14359","volume":"64","author":"Y Aiba","year":"2016","unstructured":"Aiba Y, Iwakawa M, Sakakibara R, Tsuyusaki Y, Tateno F, Kishi M, Tateno H, Ogata T (2016) Myasthenia gravis manifesting as head drop in an elderly adult with Parkinson\u2019s disease. J Am Geriatr Soc 64(10):e120\u2013e122. https:\/\/doi.org\/10.1111\/jgs.14359","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"7349_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.33588\/rn.6209.2016063","volume":"62","author":"JM Aragones","year":"2016","unstructured":"Aragones JM, Roca-Rabionet C, Altimiras-Roset J, Roura-Poch P (2016) Dropped head as the presenting symptom of myasthenia in Parkinson\u2019s disease: a characteristic association? Rev Neurol 62(9):429\u2013430. https:\/\/doi.org\/10.33588\/rn.6209.2016063","journal-title":"Rev Neurol"},{"key":"7349_CR18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jclinane.2016.05.033","volume":"34","author":"AB Ozer","year":"2016","unstructured":"Ozer AB, Catak T, Ozdemir M, Kilinc M (2016) Anesthesia management in the coexistence of myasthenia gravis and parkinsonism. J Clin Anesth 34:350\u2013351. https:\/\/doi.org\/10.1016\/j.jclinane.2016.05.033","journal-title":"J Clin Anesth"},{"key":"7349_CR19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.parkreldis.2016.04.005","volume":"28","author":"G Sciacca","year":"2016","unstructured":"Sciacca G, Nicoletti A, Mostile G, Dibilio V, Raciti L, Luca A, Reggio E, Zappia M (2016) Is it just a coincidence? Three new cases of myasthenia gravis associated with Parkinson\u2019s disease. Parkinsonism Relat Disord 28:166\u2013168. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.04.005","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"7349_CR20","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/ggi.12558","volume":"16","author":"Y Tung-Chen","year":"2016","unstructured":"Tung-Chen Y, Bataller L, Sevilla T, L\u00f3pez-Aldeguer J (2016) Co-occurrence of myasthenia gravis with Parkinson\u2019s disease: a not to be missed diagnosis. Geriatr Gerontol Int 16(4):528\u2013530. https:\/\/doi.org\/10.1111\/ggi.12558","journal-title":"Geriatr Gerontol Int"},{"issue":"376","key":"7349_CR21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jns.2017.03.026","volume":"15","author":"EJ Hogg","year":"2017","unstructured":"Hogg EJ, Lewis RA, Bannykh S, Tagliati M (2017) Head drop in Parkinson\u2019s disease complicated by myasthenia gravis and myopathy. J Neurol Sci 15(376):216\u2013218. https:\/\/doi.org\/10.1016\/j.jns.2017.03.026","journal-title":"J Neurol Sci"},{"issue":"4","key":"7349_CR22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00115-017-0378-z","volume":"89","author":"PP Urban","year":"2018","unstructured":"Urban PP, Stammel O (2018) [Myasthenia gravis should be considered in cases of Parkinson\u2019s disease and progressive dysphagia]. Nervenarzt 89(4):443\u2013445. https:\/\/doi.org\/10.1007\/s00115-017-0378-z","journal-title":"Nervenarzt"},{"key":"7349_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clineuro.2019.02.009","volume":"179","author":"M Marano","year":"2019","unstructured":"Marano M, Lanzone J, di Biase L, Pepe A, Di Santo A, Di Lazzaro V (2019) A rare cause of axial worsening in Parkinson\u2019s disease: a case of myasthenic pseudo-parkinsonism. Clin Neurol Neurosurg 179:1\u20133. https:\/\/doi.org\/10.1016\/j.clineuro.2019.02.009","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"7349_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/medicina56010005","volume":"56","author":"I Odajiu","year":"2019","unstructured":"Odajiu I, Davidescu EI, Mitu C, Popescu BO (2019) Patients with Parkinson\u2019s disease and myasthenia gravis-a report of three new cases and review of the literature. Medicina (Kaunas) 56(1):5. https:\/\/doi.org\/10.3390\/medicina56010005","journal-title":"Medicina (Kaunas)"},{"issue":"6","key":"7349_CR25","doi-asserted-by":"publisher","first-page":"502","DOI":"10.5603\/PJNNS.a2020.0092","volume":"54","author":"K \u015ami\u0142owska","year":"2020","unstructured":"\u015ami\u0142owska K, Wowra B, S\u0142awek J (2020) Double vision in Parkinson\u2019s disease: a systematic review. Neurol Neurochir Pol 54(6):502\u2013507. https:\/\/doi.org\/10.5603\/PJNNS.a2020.0092","journal-title":"Neurol Neurochir Pol"},{"issue":"5","key":"7349_CR26","doi-asserted-by":"publisher","first-page":"e14839","DOI":"10.7759\/cureus.14839","volume":"13","author":"MS Albassam","year":"2021","unstructured":"Albassam MS, Thabet SA, Hmoud M, Makkawi S (2021) Anti-muscle specific kinase (anti-MuSK) positive myasthenia gravis overlapping with Parkinson\u2019s disease: a challenging diagnosis. Cureus 13(5):e14839. https:\/\/doi.org\/10.7759\/cureus.14839","journal-title":"Cureus"},{"key":"7349_CR27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.parkreldis.2021.06.016","volume":"89","author":"JT Alshaikh","year":"2021","unstructured":"Alshaikh JT, Mills K (2021) Coincident parkinsonism and myasthenia gravis: a case series. Parkinsonism Relat Disord 89:4\u20135. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.06.016","journal-title":"Parkinsonism Relat Disord"},{"key":"7349_CR28","doi-asserted-by":"publisher","unstructured":"Iori E, Mazzoli M, Ariatti A, Salviato T, Rispoli V, Valzania F, Galassi G (2022) Myasthenia gravis crossing Parkinson\u2019s disease: a 20 year study from single Italian center. Int J Neurosci:1\u20137. https:\/\/doi.org\/10.1080\/00207454.2022.2107517","DOI":"10.1080\/00207454.2022.2107517"},{"issue":"1","key":"7349_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","volume":"19","author":"A Heidari","year":"2022","unstructured":"Heidari A, Yazdanpanah N, Rezaei N (2022) The role of Toll-like receptors and neuroinflammation in Parkinson\u2019s disease. J Neuroinflammation 19(1):135. https:\/\/doi.org\/10.1186\/s12974-022-02496-w","journal-title":"J Neuroinflammation"},{"issue":"6","key":"7349_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","volume":"16","author":"EK Tan","year":"2020","unstructured":"Tan EK, Chao YX, West A, Chan LL, Poewe W, Jankovic J (2020) Parkinson disease and the immune system - associations, mechanisms and therapeutics. Nat Rev Neurol 16(6):303\u2013318. https:\/\/doi.org\/10.1038\/s41582-020-0344-4","journal-title":"Nat Rev Neurol"},{"key":"7349_CR31","doi-asserted-by":"publisher","first-page":"1103053","DOI":"10.3389\/fimmu.2023.1103053","volume":"14","author":"M Li","year":"2023","unstructured":"Li M, Wan J, Xu Z, Tang B (2023) The association between Parkinson\u2019s disease and autoimmune diseases: a systematic review and meta-analysis. Front Immunol 14:1103053. https:\/\/doi.org\/10.3389\/fimmu.2023.1103053. (eCollection 2023)","journal-title":"Front Immunol"},{"key":"7349_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.parkreldis.2021.05.026","volume":"88","author":"E Menozzi","year":"2021","unstructured":"Menozzi E, Mulroy E, Akbarian-Tefaghi L, Bhatia KP, Balint B (2021) Movement disorders in systemic autoimmune diseases: clinical spectrum, ancillary investigations, pathophysiological considerations. Parkinsonism Relat Disord 88:116\u2013128. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.05.026","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"7349_CR33","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/s41593-023-01323-6","volume":"26","author":"F Berriat","year":"2023","unstructured":"Berriat F, Lobsiger CS, Boill\u00e9e S (2023) The contribution of the peripheral immune system to neurodegeneration. Nat Neurosci 26(6):942\u2013954. https:\/\/doi.org\/10.1038\/s41593-023-01323-6","journal-title":"Nat Neurosci"},{"issue":"6","key":"7349_CR34","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1001\/jamaneurol.2023.0932","volume":"80","author":"J Kang","year":"2023","unstructured":"Kang J, Eun Y, Jang W, Cho MH, Han K, Jung J, Kim Y, Kim GT, Shin DW, Kim H (2023) Rheumatoid arthritis and risk of Parkinson disease in Korea. JAMA Neurol 80(6):634\u2013641. https:\/\/doi.org\/10.1001\/jamaneurol.2023.0932","journal-title":"JAMA Neurol"},{"issue":"18","key":"7349_CR35","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1212\/WNL.0b013e3181c06635","volume":"73","author":"K Rugbjerg","year":"2009","unstructured":"Rugbjerg K, Friis S, Ritz B, Schernhammer ES, Korbo L, Olsen JH (2009) Autoimmune disease and risk for Parkinson disease: a population-based case-control study. Neurology 73(18):1462\u20131468. https:\/\/doi.org\/10.1212\/WNL.0b013e3181c06635","journal-title":"Neurology"},{"key":"7349_CR36","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1001\/archneur.58.10.1580","volume":"58","author":"K Hisanaga","year":"2001","unstructured":"Hisanaga K, Asagi M, Itoyama Y, Iwasaki Y (2001) Increase in peripheral CD4 bright+ CSD dull+ cell in Parkinson disease. Arch Neurol 58:1580\u20131583. https:\/\/doi.org\/10.1001\/archneur.58.10.1580","journal-title":"Arch Neurol"},{"key":"7349_CR37","doi-asserted-by":"publisher","first-page":"3160486","DOI":"10.1155\/2016\/3160486","volume":"2016","author":"R Arreola","year":"2016","unstructured":"Arreola R, Alvarez-Herrera S, P\u00e9rez-S\u00e1nchez G, Becerril-Villanueva E, Cruz-Fuentes C, Flores-Gutierrez EO, Garc\u00e9s-Alvarez ME, de la Cruz-Aguilera DL, Medina-Rivero E, Hurtado-Alvarado G, Quintero-Fabi\u00e1n S, Pav\u00f3n L (2016) Immunomodulatory effects mediated by dopamine. J Immunol Res 2016:3160486. https:\/\/doi.org\/10.1155\/2016\/3160486","journal-title":"J Immunol Res"},{"issue":"11","key":"7349_CR38","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22(11):657\u2013673. https:\/\/doi.org\/10.1038\/s41577-022-00684-6","journal-title":"Nat Rev Immunol"},{"issue":"s1","key":"7349_CR39","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.3233\/JPD-223180","volume":"12","author":"P Gonzalez-Latapi","year":"2022","unstructured":"Gonzalez-Latapi P, Marras C (2022) Epidemiological evidence for an immune component of Parkinson\u2019s disease. J Parkinsons Dis 12(s1):S29\u2013S43. https:\/\/doi.org\/10.3233\/JPD-223180","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"7349_CR40","doi-asserted-by":"publisher","first-page":"a009381","DOI":"10.1101\/cshperspect.a009381","volume":"2","author":"RL Mosley","year":"2012","unstructured":"Mosley RL, Hutter-Saunders JA, Stone DK, Gendelman HE (2012) Inflammation and adaptive immunity in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2(1):a009381. https:\/\/doi.org\/10.1101\/cshperspect.a009381","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7","key":"7349_CR41","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1001\/jamaneurol.2017.0469","volume":"74","author":"A Witoelar","year":"2017","unstructured":"Witoelar A, Jansen IE, Wang Y, Desikan RS, Gibbs JR, Blauwendraat C, Thompson WK, Hernandez DG, Djurovic S, Schork AJ, Bettella F, Ellinghaus D, Franke A, Lie BA, McEvoy LK, Karlsen TH, Lesage S, Morris HR, Brice A, Wood NW, Heutink P, Hardy J, Singleton AB, Dale AM, Gasser T, Andreassen OA, Sharma M, International Parkinson\u2019s Disease Genomics Consortium (IPDGC), North American Brain Expression Consortium (NABEC), and United Kingdom Brain Expression Consortium (UKBEC) Investigators (2017) Genome-wide pleiotropy between parkinson disease and autoimmune diseases. JAMA Neurol 74(7):780\u2013792. https:\/\/doi.org\/10.1001\/jamaneurol.2017.0469","journal-title":"JAMA Neurol"},{"issue":"8","key":"7349_CR42","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic J, Tan EK (2020) Parkinson\u2019s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 91(8):795\u2013808. https:\/\/doi.org\/10.1136\/jnnp-2019-322338","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"7349_CR43","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, Tan M, Kia DA, Noyce AJ, Xue A, Bras J, Young E, von Coelln R et al (2019) Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol 18(12):1091\u20131102. https:\/\/doi.org\/10.1016\/S1474-4422(19)30320-5","journal-title":"Lancet Neurol"},{"key":"7349_CR44","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.1038\/npjparkd.2015.2","volume":"1","author":"GT Kannarkat","year":"2015","unstructured":"Kannarkat GT, Cook DA, Lee JK, Chang J, Chung J, Sandy E, Paul KC, Ritz B, Bronstein J, Factor SA, Boss JM, Tansey MG (2015) Common genetic variant association with altered HLA expression, synergy with pyrethroid exposure, and risk for Parkinson\u2019s disease: an observational and case\u2013control study. NPJ Parkinsons Dis 1:15002. https:\/\/doi.org\/10.1038\/npjparkd.2015.2","journal-title":"NPJ Parkinsons Dis"},{"issue":"1\u20132","key":"7349_CR45","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jns.2015.11.021","volume":"359","author":"S Ehsan","year":"2015","unstructured":"Ehsan S, Amirzargar A, Yekaninejad MS, Mahmoudi M, Mehravar S, Moradi B, Nafissi S (2015) Association of HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes with myasthenia gravis and its subgroups in the Iranian population. J Neurol Sci 359(1\u20132):335\u2013342. https:\/\/doi.org\/10.1016\/j.jns.2015.11.021","journal-title":"J Neurol Sci"},{"issue":"8","key":"7349_CR46","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1002\/mds.28583","volume":"36","author":"T Naito","year":"2021","unstructured":"Naito T, Satake W, Ogawa K, Suzuki K, Hirata J, Foo JN, Tan EK, Toda T, Okada Y (2021) Trans-ethnic fine-mapping of the major histocompatibility complex region linked to Parkinson\u2019s disease. Mov Disord 36(8):1805\u20131814. https:\/\/doi.org\/10.1002\/mds.28583","journal-title":"Mov Disord"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07349-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07349-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07349-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T01:02:40Z","timestamp":1718326960000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07349-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["7349"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07349-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]},"assertion":[{"value":"18 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients agreed to participate in this study and gave permission via written informed consent in accordance with a protocol approved by a local ethics committee (PR(AG)20\/2018) and following the 2013 Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"We confirm that we have read the journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}